Levonorgestrel‐releasing intrauterine system for treating menstrual disorders: A patient satisfaction questionnaire

Radesic, Bruno; Sharma, Anil

doi:10.1111/j.1479-828x.2004.00206.x

Cited by 28 publications

(19 citation statements)

References 23 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, this result has to be seen very critically, because amenorrhea was automatically countered as a negative change, independent of the women's real attitude towards it. In our analyses, amenorrhea occurred in 56.9% of Mirena users, and lighter periods in 33.7%, which is well comparable with other studies, where amenorrhea and hypomenorrhea were described in 56-88% [1,6,9].…”

Section: International Comparisonssupporting

confidence: 93%

Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: Cross-sectional study in a Central European district

Stoegerer-Hecher¹,

Kirchengast

Huber

et al. 2011

Gynecological Endocrinology

View full text Add to dashboard Cite

show abstract

Section: International Comparisonssupporting

confidence: 93%

Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: Cross-sectional study in a Central European district

Stoegerer-Hecher¹,

Kirchengast

Huber

et al. 2011

Gynecological Endocrinology

View full text Add to dashboard Cite

show abstract

“…Both arms of the horizontal portion measure 32 mm in total. The LNG‐IUD is a highly effective mode of contraception1, 2 and, because it induces hypomenorrhea or amenorrhea, it is also used to treat menorrhagia, dysmenorrhea and adenomyosis3–5.…”

mentioning

confidence: 99%

Sonographic determination of the position of a levonorgestrel intrauterine device

Schoubroeck

Bosch

Mortelman

et al. 2008

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

) is not echogenic and may be more difficult to see on ultrasound imaging. Although the vertical stem of the LNG-IUD is not clearly visible, in a sagittal section of the uterus it creates an acoustic shadow of about 2 cm between the echogenic proximal and distal ends of the stem and is seen to extend from above the isthmus to the fundus (Figure 1). Both arms of the crossbars are slightly echogenic and usually visible in a transverse section (Figure 2). The strings hanging at the proximal end are echogenic and may be seen in the cervical canal. Ideally the LNG-IUD should be located high in the uterine cavity, with both arms opened out in the fundus. To determine the location of a LNG-IUD using two-dimensional (2D) ultrasound imaging, we start with a sagittal section followed by a transverse section to identify the landmarks described above. Three-dimensional (3D) ultrasound examination may help and involves the following steps. Starting from the sagittal section, a volume is acquired with the acquisition angle set at 120 • . After reducing the size of the volume box of the region of interest (ROI), the green line of the ROI box is set to cover the IUD. To obtain good visualization of the position of the stem, as well as of both the arms, the ROI of the acquired 3D volume should then be placed just under the level of the uterine cavity in order to render the IUD's shadow (Figures 3-5 and Figures S1-S3 online).The LNG-IUD is a T-shaped device with a polyethylene frame containing barium sulfate. On the 32-mm vertical stem, there is a reservoir containing a mixture of LNG and silicone covered by a silicone membrane. Both arms of the horizontal portion measure 32 mm in total. The LNG-IUD is a highly effective mode of contraception 1,2 and, because it induces hypomenorrhea or amenorrhea, it is also used to treat menorrhagia, dysmenorrhea and adenomyosis 3 -5 .If the LNG-IUD is not visible on ultrasound examination, it has either been expulsed or has perforated the

show abstract

“…55 Ectopic pregnancies remain a possibility and occur at an estimated rate of 0.2 per 1000 women-years. This is, however, significantly lower than a quoted ectopic pregnancy rate of 3.25e4.50 in those not using any form of contraception.…”

Section: Levonorgestrel Intrauterine Systemmentioning

confidence: 99%

Menstrual Suppression for Adolescents with Developmental Disabilities

Savasi

Spitzer

Allen

et al. 2009

Journal of Pediatric and Adolescent Gynecology

View full text Add to dashboard Cite

Levonorgestrel‐releasing intrauterine system for treating menstrual disorders: A patient satisfaction questionnaire

Cited by 28 publications

References 23 publications

Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: Cross-sectional study in a Central European district

Amenorrhea and BMI as independent determinants of patient satisfaction in LNG-IUD users: Cross-sectional study in a Central European district

Sonographic determination of the position of a levonorgestrel intrauterine device

Menstrual Suppression for Adolescents with Developmental Disabilities

Contact Info

Product

Resources

About